A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

Clinical trial NCT06041256 · COMPLETED

Trial details

NCT number: NCT06041256
Sponsor: Aurion Biotech
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Corneal Edema Corneal Endothelial Dysfunction

Start date: 2023-10-18
Primary completion: 2024-10-25
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.